Annual Accounts Payable
$11.58 M
+$1.98 M+20.61%
31 December 2023
Summary:
Cara Therapeutics annual accounts payable is currently $11.58 million, with the most recent change of +$1.98 million (+20.61%) on 31 December 2023. During the last 3 years, it has risen by +$6.69 million (+136.73%). CARA annual accounts payable is now at all-time high.CARA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.54 M
-$4.21 M-62.38%
30 September 2024
Summary:
Cara Therapeutics quarterly accounts payable is currently $2.54 million, with the most recent change of -$4.21 million (-62.38%) on 30 September 2024. Over the past year, it has dropped by -$5.44 million (-68.15%). CARA quarterly accounts payable is now -83.30% below its all-time high of $15.22 million, reached on 30 September 2022.CARA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.6% | -68.2% |
| 3 y3 years | +136.7% | -52.7% |
| 5 y5 years | +165.0% | -73.3% |
CARA Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +136.7% | -83.3% | at low |
| 5 y | 5 years | at high | +165.0% | -83.3% | at low |
| alltime | all time | at high | +2354.0% | -83.3% | +438.4% |
Cara Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.54 M(-62.4%) |
| June 2024 | - | $6.75 M(+35.7%) |
| Mar 2024 | - | $4.98 M(-57.0%) |
| Dec 2023 | $11.58 M(+20.6%) | $11.58 M(+45.2%) |
| Sept 2023 | - | $7.98 M(-34.2%) |
| June 2023 | - | $12.12 M(+174.0%) |
| Mar 2023 | - | $4.42 M(-53.9%) |
| Dec 2022 | $9.60 M(+70.7%) | $9.60 M(-36.9%) |
| Sept 2022 | - | $15.22 M(+56.2%) |
| June 2022 | - | $9.74 M(+74.1%) |
| Mar 2022 | - | $5.59 M(-0.6%) |
| Dec 2021 | $5.63 M(+15.0%) | $5.63 M(+4.8%) |
| Sept 2021 | - | $5.37 M(+58.6%) |
| June 2021 | - | $3.39 M(-28.9%) |
| Mar 2021 | - | $4.76 M(-2.6%) |
| Dec 2020 | $4.89 M(-46.2%) | $4.89 M(-24.5%) |
| Sept 2020 | - | $6.48 M(+34.3%) |
| June 2020 | - | $4.83 M(-48.1%) |
| Mar 2020 | - | $9.31 M(+2.3%) |
| Dec 2019 | $9.10 M(+108.2%) | $9.10 M(-4.6%) |
| Sept 2019 | - | $9.54 M(+283.7%) |
| June 2019 | - | $2.48 M(-49.7%) |
| Mar 2019 | - | $4.94 M(+13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $4.37 M(+14.2%) | $4.37 M(+65.7%) |
| Sept 2018 | - | $2.64 M(-28.5%) |
| June 2018 | - | $3.69 M(+219.4%) |
| Mar 2018 | - | $1.16 M(-69.8%) |
| Dec 2017 | $3.83 M(-19.2%) | $3.83 M(+222.6%) |
| Sept 2017 | - | $1.19 M(-36.4%) |
| June 2017 | - | $1.86 M(+10.5%) |
| Mar 2017 | - | $1.69 M(-64.4%) |
| Dec 2016 | $4.74 M(+141.1%) | $4.74 M(+98.5%) |
| Sept 2016 | - | $2.39 M(-18.6%) |
| June 2016 | - | $2.93 M(+24.8%) |
| Mar 2016 | - | $2.35 M(+19.5%) |
| Dec 2015 | $1.97 M(+281.6%) | $1.97 M(+55.6%) |
| Sept 2015 | - | $1.26 M(+77.6%) |
| June 2015 | - | $711.00 K(-24.2%) |
| Mar 2015 | - | $938.00 K(+82.1%) |
| Dec 2014 | $515.00 K(-23.8%) | $515.00 K(-70.0%) |
| Sept 2014 | - | $1.72 M(+44.0%) |
| June 2014 | - | $1.19 M(-24.9%) |
| Mar 2014 | - | $1.59 M(+134.6%) |
| Dec 2013 | $676.00 K(+43.2%) | $676.00 K(-47.5%) |
| Sept 2013 | - | $1.29 M(+172.9%) |
| Dec 2012 | $472.00 K(-27.5%) | $472.00 K |
| Dec 2011 | $651.00 K | - |
FAQ
- What is Cara Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Cara Therapeutics?
- What is Cara Therapeutics annual accounts payable year-on-year change?
- What is Cara Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cara Therapeutics?
- What is Cara Therapeutics quarterly accounts payable year-on-year change?
What is Cara Therapeutics annual accounts payable?
The current annual accounts payable of CARA is $11.58 M
What is the all time high annual accounts payable for Cara Therapeutics?
Cara Therapeutics all-time high annual accounts payable is $11.58 M
What is Cara Therapeutics annual accounts payable year-on-year change?
Over the past year, CARA annual accounts payable has changed by +$1.98 M (+20.61%)
What is Cara Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CARA is $2.54 M
What is the all time high quarterly accounts payable for Cara Therapeutics?
Cara Therapeutics all-time high quarterly accounts payable is $15.22 M
What is Cara Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CARA quarterly accounts payable has changed by -$5.44 M (-68.15%)